Cargando…
ODP158 A Pilot Trial on the Efficacy of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness
OBJECTIVE: Maternally inherited diabetes and deafness (MIDD) is characterized by progressive insulin secretory disorder caused by impairment of mitochondrial adenosine triphosphate (ATP) production in pancreatic beta-cells. The amino acid 5-aminolevulinic acid (5-ALA) is the first heme biosynthetic...
Autores principales: | Nakamura, Yuta, Haraguchi, Ai, Shigeno, Riyoko, Horie, Ichiro, Abiru, Norio, Kawakami, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624740/ http://dx.doi.org/10.1210/jendso/bvac150.613 |
Ejemplares similares
-
Pilot Trial on the Effect of 5-Aminolevulinic Acid on Glucose Tolerance in Patients with Maternally Inherited Diabetes and Deafness
por: Nakamura, Yuta, et al.
Publicado: (2022) -
A single-arm, open-label, intervention study to investigate the improvement of glucose tolerance after administration of the 5-aminolevulinic acid (5-ALA) in the patients with mitochondrial diabetes mellitus
por: Nakamura, Yuta, et al.
Publicado: (2021) -
SAT087 Maternally Inherited Diabetes And Deafness: Support For SGLT2 Inhibitor Use
por: Pandya, Stuti, et al.
Publicado: (2023) -
SAT084 Maternally Inherited Diabetes With Deafness: A Rare And Challenging Diagnosis Of Diabetes
por: Cuan, Katherine, et al.
Publicado: (2023) -
ODP190 Efficacy of Esaxerenone on Hypertensive Patients with Type 2 Diabetes or Those with Impaired Glucose Tolerance
por: Kuwabara, Saki, et al.
Publicado: (2022)